期刊文献+

OSAHS患者个性化治疗 被引量:5

Individualized threatment of patients with obstructive sleep apea-hypopnea syndrome
原文传递
导出
摘要 阻塞性睡眠呼吸暂停低通气综合征(obstructive sleep apnea hypopnea syndrome,OSAHS)发病率极高,发病机制复杂,治疗手段种类繁多〔1-3〕,并呈现出多学科参与、多学科交叉的复杂局面。随着睡眠医学研究的蓬勃发展,相关研究机构也不断涌现,睡眠障碍疾病受到人们前所未有的高度重视。OSAHS被称为"梦中杀手",严重者可导致全身多器官多系统的病损,也是引发交通事故和生产安全等系列社会问题的元凶之一。近年来,尽管OSAHS诊疗技术和方法都取得了长足的进步, Obstructive sleep apnea-hypopnea syndrome(OSAHS)is a kind of disease with a complex etiology,a high incidence and a wide variety of therapeutic methods.as a first-line treatment of OSAHS,non-invasive continuous positive airway pressure(CPAP)encounters the problem of low compliance of theray.And other methods of treatment are all required to meet the strict of indications to obtain the effect of therapy.The large individual anatomical differences and the great variability of non anatomical factors of the upper airway stucture of OSAHS patients,determine the diversity of OSAHS treatment.The personalized therapy is an inevitable trend in the future.in this paper,the pathogenesis,treatment methods,treatment status and personalized diagnosis and treatment trends are summarized and discussed briefly in this paper.
作者 陈雄 孔维佳
出处 《临床耳鼻咽喉头颈外科杂志》 CAS 北大核心 2016年第6期437-441,共5页 Journal of Clinical Otorhinolaryngology Head And Neck Surgery
关键词 睡眠呼吸暂停低通气综合征 阻塞性 OSA表型特征 个性化治疗 精准医疗 sleep apnea hypopnea syndrome obstructive OSA phenotypic traits personalized therapy precise medical treatment
  • 相关文献

参考文献28

  • 1PEPPARD P E,YOUNG T,BARNET J H,et al.Increased prevalence of sleep-disordered breathing in adults[J].Am J Epidemiol,2013,177:1006-1014.
  • 2SFORZA E.Pharyngeal critical pressure in patients with obstructive sleep apnea syndrome:clinical implications[J].Am J Respir Crit Care Med,1999,159:149-157.
  • 3WEAVER TE,CALIK M W,FARABI S S,et al.Innovative treatments for adults with obstructive sleep apnea[J].Nat Sci Sleep,2014,6:137-147.
  • 4WELLMAN A,JORDAN A S,MALHOTRA A,et al.Ventilatory control and airway anatomy in obstructive sleep apnea[J].Am J Respir Crit Care Med,2004,170:11-11.
  • 5YOUNES M,OSTROWSKI M,THOMPSON W,et al.Chemical control stability in patients with obstructive sleep apnea[J].Am J Respir Crit Care Med,2001,163:1181-1190.
  • 6WELLMAN A,ECKERT D J,JORDAN A S,et al.A method for measuring and modeling the physiological traits causing obstructive sleep apnea[J].J Appl Physiol,2011,110:1627-1637.
  • 7KIWULL-SCHONE H,TEPPEMA L,WIEMANNM,et al.Loop gain of respiratory control upon reduced activity of carbonic anhydrase or Na+/H+exchange[J].Adv Exp Med Biol,2006,580:239-244,351-239.
  • 8LUU V.The pathogenesis of obstructive sleep apnea[J].J Thorac Dis,2015,7:1358-1372.
  • 9EDWARDS B A,CONNOLLY J G.Acetazolamide attenuates the ventilator response to arousal in patients with obstructive sleep apnea[J].Sleep,2013,36:281-285.
  • 10SCHRODER C M,PRIMEAU M M,HALLMAYERJ F,et al.Serotonin transporter polymorphism is associated with increased apnea-hypopnea index in older adults[J].Int J Geriatr Psychiatry,2014,29:227-235.

同被引文献31

引证文献5

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部